HB 8300

House·20th Congress·Filed Mar 5, 2026

An Act Establishing a Comprehensive Legal Framework for the Governance, Regulation, and Promotion of Clinical Trials in the Philippines; Establishing a National Clinical Trial Oversight and Registry; Strengthening Ethical Safeguards and Participant Protection; Promoting Equitable Access for Indigent Filipinos; Encouraging Public Private Partnerships and Participation in Multi-Regional Clinical Trials; and for Other Purposes

In plain language

The bill would set up a new office inside the FDA to oversee all human clinical trials, create a national trial registry, and introduce faster review paths while guaranteeing free participation and post‑trial care for poor patients.

HealthScience, Technology and InnovationPublic Works and Infrastructure

Automated summary by BatasWatch. It may miss nuance — read the bill text before citing it.

Author · Representative

Eric L. OlivarezReceipts →

Official sources

Similar in what they’d do, filed by any lawmaker.

HB 5560· Filed Oct 14, 2025
An Act Instituting the Food and Drug Administration as an Independent Agency, Amending Certain Sections of Republic Act No. 3720, as Amended by Republic Act No. 9711
Pending with the Committee on HEALTH since 2025-11-11Rep. Keith Micah "Atty. Mike" D.l. Tan
HB 7582· Filed Feb 3, 2026
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2026-02-09Rep. Eric L. Olivarez
HB 4259· Filed Sep 1, 2025
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2025-09-03Rep. Ferdinand Martin G. Romualdez +3
HB 9221· Filed May 12, 2026
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2026-05-18Rep. Florabel C. Yatco
HB 3868· Filed Aug 20, 2025
An Act Increasing Access to Cancer and Related Care Medicines by Mandating an Automatic or Expedited Licensing and Registration Process of Antineoplastic Drugs Sourced Overseas, While Ensuring Their Availability at Affordable Prices, Appropriating Funds Therefor, Amending for the Purpose Republic Act No. 11215, Otherwise Known as "National Integrated Cancer Control Act"
Pending with the Committee on HEALTH since 2025-08-27Rep. Stephen James T. Tan

Spot something wrong?

HB08300 · Sources: BatasWatch

In plain language

Author · Representative

Official sources

Related bills · 20th Congress

Author · Representative

Related bills · 20th Congress